High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study.

Translated title of the contribution: High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study.
  • W. Deenik
  • , B. van der Holt
  • , G.E.G. Verhoef
  • , A.V.M.B. Schattenberg
  • , L.F. Verdonck
  • , S.M.G.J. Daenen
  • , P. Zachée
  • , P.H.M Westveer
  • , W.M Smit
  • , S. Wittebol
  • , H.C. Schouten
  • , B. Löwenberg
  • , G.J. Ossenkoppele
  • , J.J. Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionHigh-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study.
Original languageUndefined/Unknown
Pages (from-to)117-125
Number of pages9
JournalAnnals of Hematology
Volume86
Issue number2
Publication statusPublished - 2007

Cite this